Aprinoia Therapeutics (Aprinoia Therapeutics) Accounts Payable & Accrued Expense : $12.07 Mil (As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Aprinoia Therapeutics Accounts Payable & Accrued Expense?

Aprinoia Therapeutics's quarterly accounts payable & accrued expense increased from Jun. 2022 ($0.00 Mil) to Dec. 2022 ($11.96 Mil) and increased from Dec. 2022 ($11.96 Mil) to Jun. 2023 ($12.07 Mil).

Aprinoia Therapeutics's annual accounts payable & accrued expense increased from . 20 ($0.00 Mil) to Dec. 2021 ($3.27 Mil) and increased from Dec. 2021 ($3.27 Mil) to Dec. 2022 ($11.96 Mil).

Aprinoia Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Aprinoia Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprinoia Therapeutics Accounts Payable & Accrued Expense Chart

Aprinoia Therapeutics Annual Data

Trend

Dec21

Dec22

Accounts Payable & Accrued Expense

3.27

11.96

Aprinoia Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23
Accounts Payable & Accrued Expense	3.27	-	11.96	12.07

Aprinoia Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Aprinoia Therapeutics (Aprinoia Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.

Aprinoia Therapeutics (Aprinoia Therapeutics) Headlines

No Headlines